The World Health Organization declared the pandemic state of coronavirus infection COVID-2019 . Worldwide restrictive measures, including Ukraine, can cause the process of clinical trials significantly and concern the interests of all investigated subjects. The regulatory organs of different countries have already responded to these changes. For example, FDA has published the Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic. MHRA has explained its opinion regarding a predicted increase of protocol deviations. The State expert center of the Ukrainian Ministry of Health published its "Recommendations about conduction of clinical trials in the conditions of coronavirus infection spreading". The pandemic is going to be a catalyst for the development of “site-less” clinical trials (virtual, decentralized, digital, hybrid, etc.) in our area. We propose you to get acquainted with the future of virtual clinical trials with materials prepared by the partners of the Ukrainian Association for Clinical Research.
In January 2020 Ukrainian Association for Clinical Research started a collaboration with international partners CISCRP (Center for Information and Study on Clinical Research Participation https://www.ciscrp.org/) та GCPpl (Good Clinical Practice Polish Association https://www.gcppl.org.pl/).
We are happy to inform you that the Ukrainian Association for Clinical Research held the teleconference with the Association of Clinical Research Professionals (ACRP) about a strategic partnership. The ACRP is one of the biggest and most renowned and authoritative non-profit organizations with more than 13,000 members who work in clinical research in more than 70 countries. The main focus of the ACRP activities is the development of professional skills, training, and certification of clinical research professionals.